Background Systemic inflammation has been linked with cancer development, cancer
cachexia and poor outcome. Advanced lung cancer inflammation index (ALI) was developed …

Background A recent study indicated that the Advanced Lung Cancer Inflammation Index
(ALI) could predict overall survival (OS) in patients with non–small-cell lung cancer …

Background Inflammation plays a critical role in the development and progression of
cancers. The advanced lung cancer inflammation index (ALI) is thought to be able to reflect …

Background The advanced lung cancer inflammation index [ALI: body mass index× serum
albumin/neutrophil-to-lymphocyte ratio (NLR)] reflects systemic host inflammation, and is …

Backgrounds Malnutrition and systemic inflammatory responses are associated with poor
overall survival (OS) in lung cancer patients, but it remains unclear which biomarkers are …

Background Systemic inflammation, the most representative tumour–host interaction, plays a
crucial role in disease progression and prognosis in patients with non‐small cell lung cancer …

Aim Systemic inflammatory response is closely related to tumor progression. We
retrospectively investigated relationships between systemic inflammatory scores, C‐reactive …

Background: The prognostic value of pretreatment systemic immune-inflammation index (SII)
in lung cancer has yet to be fully established. Methods: Relevant articles were obtained by …

Background The systemic immune‐inflammation index (SII) is correlated with patient
survival in various types of solid tumors. However, only a few studies have focused on the …

Background The relationship between systemic immune inflammation index (SII) and the
prognosis of cancer has always been a subject of intense interest. However, the prognostic …